Chorzalska, A <br/><br/>
Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.  [electronic resource] 

 -  Leukemia  Nov 2014 
 - 2165-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2014.120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Animals<br/>Antigens, CD34--metabolism<br/>Cell Adhesion--drug effects<br/>Cell Line, Transformed<br/>Cell Proliferation--drug effects<br/>Cytoskeletal Proteins--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>Fusion Proteins, bcr-abl--genetics<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Humans<br/>Integrin alpha4--metabolism<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Proteasome Endopeptidase Complex--metabolism<br/>Tumor Microenvironment--drug effects<br/>Vascular Cell Adhesion Molecule-1--metabolism